Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02235662
What this trial is testing

Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone

Who this might be right for
HIVContraception
CONRAD 86
Early research (Phase 1)Ended earlyNCT03571594
What this trial is testing

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Who this might be right for
Acromegaly
Ono Pharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Study completedNCT04893941
What this trial is testing

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 39
Early research (Phase 1)Study completedNCT00424983
What this trial is testing

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

Who this might be right for
Multiple MyelomaBreast Cancer
Novartis Pharmaceuticals 18
Early research (Phase 1)Study completedNCT03870555
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Millennium Pharmaceuticals, Inc. 6
Early research (Phase 1)Study completedNCT05062876
What this trial is testing

Compare PK, PD and Safety of the AD-214 and AD-2141

Who this might be right for
Gastroesophageal Reflux Disease
Addpharma Inc. 41
Early research (Phase 1)Study completedNCT06116617
What this trial is testing

Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants

Who this might be right for
Thrombosis
Sirius Therapeutics Co., Ltd. 40
Early research (Phase 1)Study completedNCT03558425
What this trial is testing

Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

Who this might be right for
GERD
Chong Kun Dang Pharmaceutical 41
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06270316
What this trial is testing

Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease

Who this might be right for
Fabry Disease
UniQure Biopharma B.V. 20
Early research (Phase 1)Ended earlyNCT03880487
What this trial is testing

A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

Who this might be right for
Analgesia
Kalyra Pharmaceuticals, Inc. 26
Early research (Phase 1)WithdrawnNCT02556346
What this trial is testing

Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic B-cell Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Molecular Templates, Inc.
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Testing effectiveness (Phase 2)Looking for participantsNCT05222529
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 42
Early research (Phase 1)Study completedNCT01048619
What this trial is testing

Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Traws Pharma, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00228436
What this trial is testing

Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 139
Early research (Phase 1)Study completedNCT01051505
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers

Who this might be right for
Healthy
AstraZeneca 8
Early research (Phase 1)Study completedNCT01217905
What this trial is testing

Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687

Who this might be right for
Type 2 DiabetesObesity
AstraZeneca 36
Early research (Phase 1)Study completedNCT02800811
What this trial is testing

Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104

Who this might be right for
Rheumatoid ArthritisComplication of Transplant
OSE Immunotherapeutics 64
Early research (Phase 1)Study completedNCT00740649
What this trial is testing

Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016

Who this might be right for
Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 74
Next Page